Clearstead Advisors Portfolio holdings
Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
Paycom
PAYC
$11.7B
| $304K | ﹤0.01% |
2,421
+2,418
| +80,600% | +$315K |
2020 Q4
22 quarters
|
|
927
Immuneering
IMRX
$257M
| $304K | ﹤0.01% |
60,865
| – | – |
2026 Q1
1 quarter
|
|
928
Alliance Resource Partners
ARLP
$3.45B
| $302K | ﹤0.01% |
12,612
| – | – |
2024 Q2
8 quarters
|
|
929
Public Storage
PSA
$58.9B
| $302K | ﹤0.01% |
949
+687
| +262% | +$210K |
2020 Q1
25 quarters
|
|
930
Schwab US Aggregate Bond ETF
SCHZ
$10.8B
| $301K | ﹤0.01% |
13,001
+34
| +0.3% | +$787 |
2020 Q1
25 quarters
|
|
931
Axsome Therapeutics
AXSM
$7.52B
| $298K | ﹤0.01% |
1,219
-41
| -3% | -$8.89K |
2020 Q3
23 quarters
|
|
932
iShares US Healthcare ETF
IYH
$4.6B
| $297K | ﹤0.01% |
4,428
| – | – |
2024 Q2
8 quarters
|
|
933
Avantis International Small Cap Value ETF
AVDV
$19.9B
| $295K | ﹤0.01% |
2,861
-638
| -18% | -$67.9K |
2025 Q3
3 quarters
|
|
934
Extra Space Storage
EXR
$31.1B
| $294K | ﹤0.01% |
2,024
+109
| +6% | +$15.6K |
2023 Q1
13 quarters
|
|
935
Talen Energy Corp
TLN
$16.9B
| $294K | ﹤0.01% |
765
+1
| +0.1% | +$367 |
2025 Q1
5 quarters
|
|
936
Masco
MAS
$15.3B
| $293K | ﹤0.01% |
3,600
+2,786
| +342% | +$194K |
2020 Q1
25 quarters
|
|
937
First Trust NYSE Arca Biotechnology Index Fund
FBT
$3.08B
| $292K | ﹤0.01% |
1,179
| – | – |
2021 Q4
18 quarters
|
|
938
AB InBev
BUD
$154B
| $289K | ﹤0.01% |
3,507
+3,417
| +3,797% | +$269K |
2023 Q1
13 quarters
|
|
939
FirstEnergy
FE
$27.1B
| $285K | ﹤0.01% |
6,005
+3,349
| +126% | +$159K |
2020 Q1
25 quarters
|
|
940
Golub Capital BDC
GBDC
$3.28B
| $285K | ﹤0.01% |
22,111
+18,868
| +582% | +$246K |
2023 Q2
12 quarters
|
|
941
Aecom
ACM
$8.15B
| $284K | ﹤0.01% |
4,071
+178
| +5% | +$13.6K |
2021 Q1
21 quarters
|
|
942
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.87B
| $284K | ﹤0.01% |
2,603
+93
| +4% | +$9.6K |
2025 Q2
4 quarters
|
|
943
Quantum Computing Inc
QUBT
$1.56B
| $283K | ﹤0.01% |
29,179
+10,000
| +52% | +$97.3K |
2025 Q4
2 quarters
|
|
944
Sprott Physical Silver Trust
PSLV
$10.7B
| $283K | ﹤0.01% |
14,977
-5,480
| -27% | -$129K |
2025 Q4
2 quarters
|
|
945
VeriSign
VRSN
$27.3B
| $283K | ﹤0.01% |
1,123
-235
| -17% | -$65.3K |
2025 Q1
5 quarters
|
|
946
Steris
STE
$22.5B
| $281K | ﹤0.01% |
1,335
+145
| +12% | +$31.1K |
2019 Q4
26 quarters
|
|
947
iShares Preferred and Income Securities ETF
PFF
$11.9B
| $281K | ﹤0.01% |
9,211
+1,201
| +15% | +$37.4K |
2020 Q1
25 quarters
|
|
948
Atlantic Union Bankshares
AUB
$5.59B
| $281K | ﹤0.01% |
6,635
+99
| +2% | +$3.78K |
2024 Q2
8 quarters
|
|
949
Lyell Immunopharma
LYEL
$284M
| $280K | ﹤0.01% |
19,958
-19,958
| -50% | -$361K |
2026 Q1
1 quarter
|
|
950
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.44B
| $278K | ﹤0.01% |
2,419
+1,819
| +303% | +$202K |
2023 Q4
10 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,519 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,519 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.